Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI038185-02
Application #
2075135
Study Section
AIDS and Related Research Study Section 5 (ARRE)
Project Start
1995-08-01
Project End
1999-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205
Barrow, Esther L W; Barrow, William W; Quenelle, Debra C et al. (2007) Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice. Drug Deliv 14:119-27
Barrow, William W (2004) Microsphere technology for chemotherapy of mycobacterial infections. Curr Pharm Des 10:3275-84
Barrow, W W (2001) Treatment of mycobacterial infections. Rev Sci Tech 20:55-70
Quenelle, D C; Winchester, G A; Staas, J K et al. (2001) Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Antimicrob Agents Chemother 45:1637-44
Quenelle, D C; Staas, J K; Winchester, G A et al. (1999) Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice. Antimicrob Agents Chemother 43:1144-51
Barrow, E L; Winchester, G A; Staas, J K et al. (1998) Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages. Antimicrob Agents Chemother 42:2682-9
Wright, E L; Quenelle, D C; Suling, W J et al. (1996) Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies. Antimicrob Agents Chemother 40:2206-8